catechin has been researched along with Idiopathic Pulmonary Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chandoesing, PP; de Bruijn, P; Koolen, SLW; Mathijssen, RHJ; Miedema, JR; Oomen-de Hoop, E; van der Mark, SC; van der Werff, SC; Veerman, GDM; Wijsenbeek, MS | 1 |
| Akiyama, Y; Hara, A; Ishihara, J; Ishimatsu, Y; Ishimoto, H; Kido, T; Miyamura, T; Moriyama, S; Mukae, H; Okuno, D; Sakamoto, N; Tagod, MSO; Takeda, K; Tanaka, T; Tanaka, Y | 1 |
| Chang, KF; Chang, WA; Kuo, PL; Liao, SH; Sheu, CC; Tsai, MJ | 1 |
1 trial(s) available for catechin and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
The influence of green tea extract on nintedanib's bioavailability in patients with pulmonary fibrosis.
Topics: Antioxidants; Biological Availability; Biological Products; Catechin; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Plant Extracts; Prospective Studies; Tea | 2022 |
2 other study(ies) available for catechin and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Screening of Inhibitors Targeting Heat Shock Protein 47 Involved in the Development of Idiopathic Pulmonary Fibrosis.
Topics: Catechin; Dose-Response Relationship, Drug; Drug Development; Drug Evaluation, Preclinical; HSP47 Heat-Shock Proteins; Humans; Idiopathic Pulmonary Fibrosis; Molecular Structure; Structure-Activity Relationship | 2021 |
The Effects of Epigallocatechin Gallate (EGCG) on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)-A Next-Generation Sequencing and Bioinformatic Approach.
Topics: Biomarkers; Catechin; Computational Biology; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; High-Throughput Nucleotide Sequencing; Humans; Idiopathic Pulmonary Fibrosis; MicroRNAs; Transcriptome | 2019 |